MaryPMcGowanMD

PubMed

• Universal Pediatric Cholesterol Screening: The Time Has Come!
  McGowan, M., Peterson, A.> ;The Journal of Pediatrics. 2024 Feb 1
• Universal paediatric screening for familial hypercholesterolaemia.
  Cuchel, M., McGowan, M.> ;Lancet. 2024 Jan 6
• 3 citations
  Familial hypercholesterolaemia: too many lost opportunities.
  Marina Cuchel, Mary P. McGowan> ;Lancet. 2021 Sep 7
• Letter to the Editor in response to "Response to Kovanen PT, et al. Letter to the Editor" for original article COVID-19 increases risk of myocardial infarction in pers...
  Kelly D. Myers, Katherine Wilemon, Mary P. McGowan, William James Howard, David Staszak, Daniel J. Rader> ;American Journal of Preventive Cardiology. 2021 Jul 20
• 12 citations
  Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia:...
  Laney K. Jones, Nicole Walters, Andrew Brangan, Catherine D. Ahmed, Michael Gatusky, Gemme Campbell-Salome, Ilene G. Ladd, Amanda Sheldon, Samuel S. Gidding, Mary P. M...> ;Journal of Personalized Medicine. 2021 Jun 1
• 17 citations
  COVID-19 associated risks of myocardial infarction in persons with familial hypercholesterolemia with or without ASCVD.
  Kelly D. Myers, Katherine Wilemon, Mary P. McGowan, William James Howard, David Staszak, Daniel J. Rader> ;American Journal of Preventive Cardiology. 2021 May 25
• 12 citations
  A proof-of-concept study of cascade screening for Familial Hypercholesterolemia in the US, adapted from the Dutch model
  Mary P. McGowan, Marina Cuchel, Catherine D. Ahmed, Amit Khera, William S. Weintraub, Katherine Wilemon, Zahid Ahmad> ;American Journal of Preventive Cardiology. 2021 Mar 11
• 23 citations
  Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis: Identification Methods, Patient Activation, and Cascade Testing for...
  Gemme Campbell-Salome, Laney K. Jones, Max F. Masnick, Nephi A. Walton, Catherine D. Ahmed, Adam H. Buchanan, Andrew Brangan, Edward D. Esplin, David Kann, Ilene G. La...> ;Circulation. Genomic and Precision Medicine. 2021 Jan 22
• 87 citations
  Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia
  Mary P. McGowan, Seyed Hamed Hosseini Dehkordi, Patrick M. Moriarty, P. Barton Duell> ;Journal of the American Heart Association. 2019 Dec 17
• 38 citations
  Liver histology during Mipomersen therapy for severe hypercholesterolemia
  Nikroo Hashemi, Robert D. Odze, Mary P. McGowan, Raul D. Santos, Erik S.G. Stroes, David E. Cohen> ;Journal of Clinical Lipidology. 2014 Nov 1
• 17 citations
  Emerging low-density lipoprotein (LDL) therapies: Management of severely elevated LDL cholesterol—The role of LDL-apheresis
  Mary P. McGowan> ;Journal of Clinical Lipidology. 2013 May 1
• 151 citations
  Randomized, Placebo-Controlled Trial of Mipomersen in Patients with Severe Hypercholesterolemia Receiving Maximally Tolerated Lipid-Lowering Therapy
  Mary P. McGowan, Jean-Claude Tardif, Richard Ceska, Lesley J. Burgess, Handrean Soran, Ioanna Gouni-Berthold, Gilbert Wagener, Scott Chasan-Taber> ;Plos One. 2012 Nov 13
• 219 citations
  Apolipoprotein B Synthesis Inhibition With Mipomersen in Heterozygous Familial Hypercholesterolemia Results of a Randomized, Double-Blind, Placebo-Controlled Trial to ...
  Evan A. Stein, Robert Dufour, Claude Gagné, Daniel Gaudet, Cara East, Joanne M. Donovan, Wai Chin, Diane Tribble, Mary P. McGowan> ;Circulation. 2012 Nov 6
• 90 citations
  Management of familial hypercholesterolemias in adult patients: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
  Matthew K. Ito, Mary P. McGowan, Patrick M. Moriarty> ;Journal of Clinical Lipidology. 2011 Jun 1
• Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel ...
  Goldberg AC, Hopkins PN, Toth PP, Ballantyne CM, Rader DJ, Robinson JG, Daniels SR, Gidding SS, de Ferranti SD, Ito MK, McGowan MP, Moriarty PM, Cromwell WC, Ross JL, ...> ;J Clin Lipidol. 2011-06-01
• 28 citations
  Polycystic ovary syndrome: a common endocrine disorder and risk factor for vascular disease.
  Mary P. McGowan> ;Current Treatment Options in Cardiovascular Medicine. 2011 May 12
• 332 citations
  Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients
  Anne C. Goldberg, Paul N. Hopkins, Peter P. Toth, Christie M. Ballantyne, Daniel J. Rader, Jennifer G. Robinson, Stephen R. Daniels, Samuel S. Gidding, Sarah D. de Fer...> ;Journal of Clinical Lipidology. 2011 May 1
• 2 citations
  NLA Symposium screening and treatment of familial hypercholesterolemia: How can we do better? Opening and introductions
  Mary P. McGowan> ;Journal of Clinical Lipidology. 2010 Sep 1
• Question-and-answer session
  Mary P. McGowan> ;Journal of Clinical Lipidology. 2010 Sep 1
• 19 citations
  Nutritional supplements and serum lipids: does anything work?
  Mary P. McGowan, Suzanne Proulx> ;Current Atherosclerosis Reports. 2009 Nov 5
• 65 citations
  There Is No Evidence for an Increase in Acute Coronary Syndromes After Short-Term Abrupt Discontinuation of Statins in Stable Cardiac Patients
  Mary P. McGowan> ;Circulation. 2004 Oct 19
• 148 citations
  Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit?
  David D. Waters, John R. Guyton, David M. Herrington, Mary P McGowan, Nanette K. Wenger, Charles L. Shear> ;The American Journal of Cardiology. 2004 Jan 15
• 14 citations
  Primary testicular choriocarcinoma with pulmonary metastases presenting as ARDS.
  Mary P. McGowan, Melvin R. Pratter, Gerald Nash> ;Chest. 1990 May 1
• Join now to see all